Is HLOSF or DIVO a better dividend investment in 2026?

HLOSF currently yields 90.91% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: HLOSF offers higher current income.

What is the dividend yield difference between HLOSF and DIVO?

HLOSF has a forward dividend yield of 90.91% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 84.42 percentage points.

Home › Compare › HLOSF vs DIVO

HLOSF vs DIVO: Dividend Comparison 2026

HLOSF yields 90.91% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HLOSF wins by $2.64M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HLOSF

● Live price

90.91%

Share price

$2.20

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2.67M

Annual income

$842,999.04

Full HLOSF calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — HLOSF vs DIVO

📍 HLOSF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HLOSF	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HLOSF + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HLOSF pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HLOSF

Annual income on $10K today (after 15% tax)

$7,727.27/yr

After 10yr DRIP, annual income (after tax)

$716,549.18/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, HLOSF beats the other by $715,714.76/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HLOSF + DIVO for your $10,000?

HLOSF: 50%DIVO: 50%

100% DIVO50/50100% HLOSF

Portfolio after 10yr

$1.35M

Annual income

$421,990.36/yr

Blended yield

31.28%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on HLOSF right now

HLOSF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

1.9

Piotroski

2/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HLOSF buys

DIVO buys

No recent congressional trades found for HLOSF or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHLOSFDIVO

Forward yield	90.91% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$2.67M	$30.7K ✓
Annual income after 10y	$842,999.04 ✓	$981.68
Total dividends collected	$2.36M	$8.2K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: HLOSF vs DIVO ($10,000, DRIP)

Year	HLOSF Portfolio	HLOSF Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$19,791	$9,090.91	$11,349	$649.42	+$8.4K → HLOSF
2	$37,991	$16,814.71	$12,833	$688.83	+$25.2K → HLOSF
3	$70,817	$30,166.17	$14,459	$727.90	+$56.4K → HLOSF
4	$128,326	$52,552.16	$16,238	$766.49	+$112.1K → HLOSF
5	$226,308	$88,999.24	$18,179	$804.47	+$208.1K → HLOSF
6	$388,835	$146,685.82	$20,293	$841.71	+$368.5K → HLOSF
7	$651,597	$235,543.05	$22,591	$878.14	+$629.0K → HLOSF
8	$1,066,101	$368,892.48	$25,087	$913.65	+$1.04M → HLOSF
9	$1,704,801	$564,073.19	$27,791	$948.18	+$1.68M → HLOSF
10	$2,667,136	$842,999.04	$30,718	$981.68	+$2.64M → HLOSF

HLOSF vs DIVO: Complete Analysis 2026

HLOSF — Stock

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration; HLCL041, an iPSC regenerative medicine for the treatment of metabolic liver disease; and HLCM051, a regenerative medicine for treatment of ischemic stroke and acute respiratory distress syndrome, as well as HLCN061 for treating solid tumors. Healios K.K. has a joint research agreement with the Hyogo Medical University on cancer immunotherapies for mesothelioma using eNK cells. The company was formerly known as Retina Institute Japan, K.K. and changed its name to Healios K.K. in September 2013. Healios K.K. was incorporated in 2011 and is headquartered in Tokyo, Japan.

Full HLOSF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this HLOSF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HLOSF vs SCHD HLOSF vs JEPI HLOSF vs O HLOSF vs KO HLOSF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.